ASCVD Clinical Trials

14 recruitingLast updated: May 11, 2026

There are 14 actively recruiting ascvd clinical trials across 28 countries. Studies span Phase 3, Not Applicable, Phase 2, Phase 4. Top locations include Beijing, China, Boston, Massachusetts, United States, Miami, Florida, United States. Updated daily from ClinicalTrials.gov.


ASCVD Trials at a Glance

14 actively recruiting trials for ascvd are listed on ClinicalTrialsFinder across 6 cities in 28 countries. The largest study group is Phase 3 with 4 trials, with the heaviest enrollment activity in Beijing, Boston, and Miami. Lead sponsors running ascvd studies include Brigham and Women's Hospital, Duke University, and Atom Therapeutics Co., Ltd.

Browse ascvd trials by phase

Treatments under study

About ASCVD Clinical Trials

Looking for clinical trials for ASCVD? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ASCVD trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ASCVD clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Phase 2

Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis

ASCVDAtherosclerosis Cardiovascular DiseaseASCVD Management
Atom Therapeutics Co., Ltd200 enrolled33 locationsNCT07303777
Recruiting
Phase 3

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Atherosclerotic Cardiovascular Disease (ASCVD)Elevated Lp(a)
Eli Lilly and Company10,450 enrolled751 locationsNCT07157774
Recruiting

Aspirin 50 mg vs. 100 mg in Elderly Cardiovascular Disease Patients

Cardiovascular DiseasesAtherosclerotic Cardiovascular Disease (ASCVD)Secondary Prevention
Peking University First Hospital5,448 enrolled1 locationNCT07542860
Recruiting
Phase 3

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals340 enrolled92 locationsNCT06813911
Recruiting
Phase 2

Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis

ASCVDVascular InflammationASCVD Management
Massachusetts General Hospital120 enrolled1 locationNCT06691217
Recruiting
Phase 4

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

Type2diabetesASCVD
Brigham and Women's Hospital6,000 enrolled36 locationsNCT05390892
Recruiting
Not Applicable

Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)

Atherosclerotic Cardiovascular Disease (ASCVD)Familial Hypercholesterolemias
Nantes University Hospital600 enrolled9 locationsNCT06960902
Recruiting

Optimizing Non-statin Agents for ASCVD

ASCVD Management
University of Texas at Austin1,000 enrolled1 locationNCT07464574
Recruiting
Phase 3

Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease

Atherosclerotic Cardiovascular Disease (ASCVD)Atherothrombotic Diseases
Hospital do Coracao7,713 enrolled13 locationsNCT06930885
Recruiting

The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study

Rheumatoid Arthritis (RA)Atherosclerotic Cardiovascular Disease (ASCVD)
Brigham and Women's Hospital120 enrolled1 locationNCT07315997
Recruiting

The Long-term Effect of Remote Ischemic Conditioning on Main Organs in ASVCD Patients With Very High Risks

ASCVD
General Hospital of Shenyang Military Region2,800 enrolled1 locationNCT07270887
Recruiting
Not Applicable

Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?

ASCVDLDL-C
Duke University400 enrolled1 locationNCT06471036
Recruiting
Phase 4

Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus

DiabetesASCVDStatin
Korea University Anam Hospital2,000 enrolled1 locationNCT06767774
Recruiting
Phase 3

A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia

Primary hypercholesterolemiaMetabolic DiseaseDyslipidemias+4 more
Hasten Biopharmaceutical Co., Ltd.210 enrolled18 locationsNCT06568471